FDA
- Status: approved
🇺🇸 Sildenafil therapy plus post-NSRRP HBO2T in United States
Sildenafil therapy plus post-NSRRP HBO2T (Sildenafil therapy plus post-NSRRP HBO2T) regulatory status in United States.
Marketing authorisation
Sildenafil therapy plus post-NSRRP HBO2T in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Sildenafil therapy plus post-NSRRP HBO2T approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Sildenafil therapy plus post-NSRRP HBO2T in United States?
Hartford Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.